![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Pinto, NG Abraham and KM Mullane
Arachidonic acid (AA, 10(-8)-5 X 10(-6) M) induced dose-dependent relaxations of canine coronary arterial rings precontracted with dinoprost that were significantly greater (P less than .001) if the endothelium was intact. Cyclooxygenase inhibition with indomethacin displaced the dose-response curve to AA to the right but did not prevent the relaxant effects of the fatty acid. SKF-525A, an inhibitor of cytochrome P-450-dependent enzymes, also attenuated the response to AA although the combination of SKF-525A and indomethacin prevented any relaxant effect. Induction of cytochrome P-450-dependent enzymes in the coronary artery with 3-methylcholanthrene and beta-naphthoflavone given in vivo (40 mg/kg/day for 3 days) or depletion of these enzymes with cobalt chloride (24 mg/kg/day for 2 days) resulted in an enhancement or diminution, respectively, of AA-induced endothelial-dependent relaxations. These results implicate a cytochrome P-450-dependent mixed function oxidase in the endothelial-dependent relaxations to AA in the canine coronary artery. Precontraction of coronary arteries with U46619 in contrast to dinoprost failed to display endothelial-dependent relaxations to AA, whereas the responses to bradykinin and acetylcholine were also partially attenuated. Pharmacologic manipulations of AA metabolism via cyclooxygenase and cytochrome P-450- dependent monooxygenases indicate that the endothelial-dependent relaxations induced by bradykinin are partially dependent upon metabolites of AA, whereas the relaxations produced by acetylcholine are independent of AA metabolites, suggesting that a number of potential relaxing factors may be released from the endothelium.
This article has been cited by other articles:
|
|
 |
|
  J. Wray and D. Bishop-Bailey Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology Exp Physiol, January 1, 2008; 93(1): 148 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. X. Zhang, K. M. Gauthier, Y. Chawengsub, and W. B. Campbell ACh-induced relaxations of rabbit small mesenteric arteries: role of arachidonic acid metabolites and K+ Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H152 - H159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Yang, B. B. Holmes, V. R. Gopal, R. V. K. Kishore, B. Sangras, X.-Y. Yi, J. R. Falck, and W. B. Campbell Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1023 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Hagedorn, C.-L. Cooke, J. R. Falck, B. F. Mitchell, and S. T. Davidge Regulation of Vascular Tone During Pregnancy: A Novel Role for the Pregnane X Receptor Hypertension, February 1, 2007; 49(2): 328 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Larsen, H. Miura, O. A. Hatoum, W. B. Campbell, B. D. Hammock, D. C. Zeldin, J. R. Falck, and D. D. Gutterman Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H491 - H499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. X. Zhang, K. M. Gauthier, Y. Chawengsub, B. B. Holmes, and W. B. Campbell Cyclooxygenase- and lipoxygenase-dependent relaxation to arachidonic acid in rabbit small mesenteric arteries Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H302 - H309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nithipatikom, E. R. Gross, M. P. Endsley, J. M. Moore, M. A. Isbell, J. R. Falck, W. B. Campbell, and G. J. Gross Inhibition of Cytochrome P450{omega}-Hydroxylase: A Novel Endogenous Cardioprotective Pathway Circ. Res., October 15, 2004; 95(8): e65 - e71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Spiecker, H. Darius, T. Hankeln, M. Soufi, A. M. Sattler, J. R. Schaefer, K. Node, J. Borgel, A. Mugge, K. Lindpaintner, et al. Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 Circulation, October 12, 2004; 110(15): 2132 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Gauthier, N. Spitzbarth, E. M. Edwards, and W. B. Campbell Apamin-Sensitive K+ Currents Mediate Arachidonic Acid-Induced Relaxations of Rabbit Aorta Hypertension, February 1, 2004; 43(2): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Gauthier, S. G. Jagadeesh, J. R. Falck, and W. B. Campbell 14,15-Epoxyeicosa-5(Z)-Enoic-mSI: A 14,15- and 5,6-EET Antagonist in Bovine Coronary Arteries Hypertension, October 1, 2003; 42(4): 555 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Gauthier, C. Deeter, U. M. Krishna, Y. K. Reddy, M. Bondlela, J.R. Falck, and W. B. Campbell 14,15-Epoxyeicosa-5(Z)-enoic Acid: A Selective Epoxyeicosatrienoic Acid Antagonist That Inhibits Endothelium-Dependent Hyperpolarization and Relaxation in Coronary Arteries Circ. Res., May 17, 2002; 90(9): 1028 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. J. Halcox, S. Narayanan, L. Cramer-Joyce, R. Mincemoyer, and A. A. Quyyumi Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2470 - H2477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rastaldo, N. Paolocci, A. Chiribiri, C. Penna, D. Gattullo, and P. Pagliaro Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2823 - H2832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fukao, H. S. Mason, J. L. Kenyon, B. Horowitz, and K. D. Keef Regulation of BKca Channels Expressed in Human Embryonic Kidney 293 Cells by Epoxyeicosatrienoic Acid Mol. Pharmacol., January 1, 2001; 59(1): 16 - 23. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Qiu and J. Quilley Vascular effects of arachidonic acid in the rat perfused heart: role of the endothelium, cyclooxygenase, cytochrome P450, and K+ channels J. Lipid Res., December 1, 1999; 40(12): 2177 - 2184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jacobs, R. M. Effros, J. R. Falck, K. M. Reddy, W. B. Campbell, and D. Zhu Airway synthesis of 20-hydroxyeicosatetraenoic acid: metabolism by cyclooxygenase to a bronchodilator Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L280 - L288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Pfister, N. Spitzbarth, K. Nithipatikom, W. S. Edgemond, J. R. Falck, and W. B. Campbell Identification of the 11,14,15- and 11,12,15-Trihydroxyeicosatrienoic Acids as Endothelium-derived Relaxing Factors of Rabbit Aorta J. Biol. Chem., November 20, 1998; 273(47): 30879 - 30887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Oltman, N. L. Weintraub, M. VanRollins, and K. C. Dellsperger Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids Are Potent Vasodilators in the Canine Coronary Microcirculation Circ. Res., November 2, 1998; 83(9): 932 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Miura and D. D. Gutterman Human Coronary Arteriolar Dilation to Arachidonic Acid Depends on Cytochrome P-450 Monooxygenase and Ca2+-Activated K+ Channels Circ. Res., September 7, 1998; 83(5): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dumoulin, D. Salvail, S. B. Gaudreault, A. Cadieux, and E. Rousseau Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L423 - L431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Popp, I. Fleming, and R. Busse Pulsatile Stretch in Coronary Arteries Elicits Release of Endothelium-Derived Hyperpolarizing Factor : A Modulator of Arterial Compliance Circ. Res., April 6, 1998; 82(6): 696 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okamura, K. Ayajiki, and N. Toda Monkey corpus cavernosum relaxation mediated by NO and other relaxing factor derived from nerves Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1075 - H1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-L. Li and W. B. Campbell Epoxyeicosatrienoic Acids Activate K+ Channels in Coronary Smooth Muscle Through a Guanine Nucleotide Binding Protein Circ. Res., June 19, 1997; 80(6): 877 - 884. [Abstract] [Full Text]
|
|
|
|
|
|
K. Node, M. Kitakaze, H. Kosaka, T. Minamino, and M. Hori Bradykinin Mediation of Ca2+-Activated K+ Channels Regulates Coronary Blood Flow in Ischemic Myocardium Circulation, March 18, 1997; 95(6): 1560 - 1567. [Abstract] [Full Text]
|
|
|
|
|
|
G. Chen and D. W. Cheung Modulation of Endothelium-Dependent Hyperpolarization and Relaxation to Acetylcholine in Rat Mesenteric Artery by Cytochrome P450 Enzyme Activity Circ. Res., October 1, 1996; 79(4): 827 - 833. [Abstract] [Full Text]
|
|
|
|
|
|
L. Puybasset, M.-L. Bea, B. Ghaleh, J.-F. Giudicelli, and A. Berdeaux Coronary and Systemic Hemodynamic Effects of Sustained Inhibition of Nitric Oxide Synthesis in Conscious Dogs: Evidence for Cross Talk Between Nitric Oxide and Cyclooxygenase in Coronary Vessels Circ. Res., August 1, 1996; 79(2): 343 - 357. [Abstract] [Full Text]
|
|
|
|
|
|
P. F. Pratt, M. Rosolowsky, and W. B. Campbell Mediators of Arachidonic Acid–Induced Relaxation of Bovine Coronary Artery Hypertension, July 1, 1996; 28(1): 76 - 82. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Cohen and P. M. Vanhoutte Endothelium-Dependent Hyperpolarization : Beyond Nitric Oxide and Cyclic GMP Circulation, December 1, 1995; 92(11): 3337 - 3349. [Full Text]
|
|
|
|
|
|
N. L. Weintraub, A. H. Stephenson, R. S. Sprague, L. McMurdo, and A. J. Lonigro Relationship of Arachidonic Acid Release to Porcine Coronary Artery Relaxation Hypertension, October 1, 1995; 26(4): 684 - 690. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
